Fig. 1 · Structure

Documents & Downloads

Asnuciclib (CDKI-73)

Cat. No. A21467 CAS 1421693-22-2

CDK9 inhibitor

CDKI-73 is a potent CDK9 inhibitor with Ki of 4 nM; shows selective toxicity to CLL cells(LD50=80 nM) versus normal B cell and normal CD34+ cell(LD50>20 uM).

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Target & Activity

Target Activity Value
CDK2 IC50 3.27 nM
CDK9 IC50 5.78 nM
CDK1 IC50 8.17 nM
CDK4 IC50 8.18 nM
CDK6 IC50 37.68 nM
CDK7 IC50 134.26 nM
CDK1 Ki 4 nM
CDK2 Ki 3 nM
CDK9 Ki 4 nM
CDK7 Ki 91 nM

10 targets · Scroll to view more

Cellular Effect

Cell Line Activity Value Description Reference
HCT-116 GI50 < 0.01 μM Cytotoxicity against human HCT116 cells after 48 hrs by MTT assay [PMID: 23301767]

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 1421693-22-2
Applications CDK9 inhibitor
Formula C15H15FN6O2S2
Molecular Weight 394.45
Synonyms CDKI73; LS-007
SMILES
CNC1=NC(C)=C(C2=C(F)C=NC(NC3=CC(S(=O)(N)=O)=CC=C3)=N2)S1

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 77 mg/mL (195.2 mM)
Water Insoluble
Ethanol 1 mg/mL (2.53 mM)

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...